nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—TOP2A—prostate cancer	0.328	1	CbGaD
Sparfloxacin—TOP2A—Mitoxantrone—prostate cancer	0.071	0.157	CbGbCtD
Sparfloxacin—TOP2A—Epirubicin—prostate cancer	0.0575	0.127	CbGbCtD
Sparfloxacin—TOP2A—Etoposide—prostate cancer	0.0448	0.0993	CbGbCtD
Sparfloxacin—ABCC2—Ethinyl Estradiol—prostate cancer	0.0437	0.0968	CbGbCtD
Sparfloxacin—ABCC2—Conjugated Estrogens—prostate cancer	0.0321	0.071	CbGbCtD
Sparfloxacin—TOP2A—Doxorubicin—prostate cancer	0.0306	0.0677	CbGbCtD
Sparfloxacin—ABCB1—Estramustine—prostate cancer	0.0248	0.0549	CbGbCtD
Sparfloxacin—ABCC2—Etoposide—prostate cancer	0.0184	0.0407	CbGbCtD
Sparfloxacin—ABCC2—Docetaxel—prostate cancer	0.0168	0.0373	CbGbCtD
Sparfloxacin—ABCB1—Cabazitaxel—prostate cancer	0.0163	0.0362	CbGbCtD
Sparfloxacin—ABCB1—Estrone—prostate cancer	0.016	0.0354	CbGbCtD
Sparfloxacin—ABCB1—Ethinyl Estradiol—prostate cancer	0.0142	0.0316	CbGbCtD
Sparfloxacin—ABCC2—Doxorubicin—prostate cancer	0.0125	0.0278	CbGbCtD
Sparfloxacin—ABCB1—Conjugated Estrogens—prostate cancer	0.0105	0.0232	CbGbCtD
Sparfloxacin—ABCB1—Mitoxantrone—prostate cancer	0.0095	0.0211	CbGbCtD
Sparfloxacin—ABCB1—Estradiol—prostate cancer	0.00918	0.0203	CbGbCtD
Sparfloxacin—ABCB1—Prednisone—prostate cancer	0.00789	0.0175	CbGbCtD
Sparfloxacin—ABCB1—Etoposide—prostate cancer	0.00599	0.0133	CbGbCtD
Sparfloxacin—ABCB1—Docetaxel—prostate cancer	0.00548	0.0121	CbGbCtD
Sparfloxacin—ABCB1—Doxorubicin—prostate cancer	0.00409	0.00906	CbGbCtD
Sparfloxacin—TOP2A—prostate gland—prostate cancer	0.00115	0.137	CbGeAlD
Sparfloxacin—TOP2A—Docetaxel—Cabazitaxel—prostate cancer	0.000864	0.267	CbGdCrCtD
Sparfloxacin—Moxifloxacin—TOP2A—prostate cancer	0.000834	0.289	CrCbGaD
Sparfloxacin—ABCC2—prostate gland—prostate cancer	0.000786	0.0934	CbGeAlD
Sparfloxacin—SLC22A5—prostate gland—prostate cancer	0.000609	0.0724	CbGeAlD
Sparfloxacin—TOP2A—Paclitaxel—Cabazitaxel—prostate cancer	0.000597	0.184	CbGdCrCtD
Sparfloxacin—TOP2A—bone marrow—prostate cancer	0.000593	0.0704	CbGeAlD
Sparfloxacin—ABCC2—renal system—prostate cancer	0.000536	0.0637	CbGeAlD
Sparfloxacin—SLC22A5—seminal vesicle—prostate cancer	0.000515	0.0612	CbGeAlD
Sparfloxacin—TOP2A—testis—prostate cancer	0.000507	0.0602	CbGeAlD
Sparfloxacin—Lomefloxacin—TOP2A—prostate cancer	0.000431	0.149	CrCbGaD
Sparfloxacin—SLC22A5—renal system—prostate cancer	0.000415	0.0493	CbGeAlD
Sparfloxacin—SLC22A5—urethra—prostate cancer	0.000408	0.0484	CbGeAlD
Sparfloxacin—Ofloxacin—TOP2A—prostate cancer	0.000369	0.128	CrCbGaD
Sparfloxacin—Levofloxacin—TOP2A—prostate cancer	0.000369	0.128	CrCbGaD
Sparfloxacin—TOP2A—lymph node—prostate cancer	0.000367	0.0436	CbGeAlD
Sparfloxacin—Ciprofloxacin—TOP2A—prostate cancer	0.000356	0.123	CrCbGaD
Sparfloxacin—ABCC2—testis—prostate cancer	0.000346	0.0411	CbGeAlD
Sparfloxacin—ABCB1—prostate gland—prostate cancer	0.000283	0.0336	CbGeAlD
Sparfloxacin—Ciprofloxacin—CYP3A5—prostate cancer	0.000281	0.0973	CrCbGaD
Sparfloxacin—SLC22A5—testis—prostate cancer	0.000268	0.0319	CbGeAlD
Sparfloxacin—ABCC2—lymph node—prostate cancer	0.000251	0.0298	CbGeAlD
Sparfloxacin—TOP2A—Paclitaxel—Docetaxel—prostate cancer	0.000248	0.0765	CbGdCrCtD
Sparfloxacin—ABCB1—seminal vesicle—prostate cancer	0.000239	0.0284	CbGeAlD
Sparfloxacin—ABCB1—epithelium—prostate cancer	0.000208	0.0247	CbGeAlD
Sparfloxacin—SLC22A5—lymph node—prostate cancer	0.000194	0.0231	CbGeAlD
Sparfloxacin—ABCB1—renal system—prostate cancer	0.000193	0.0229	CbGeAlD
Sparfloxacin—ABCB1—urethra—prostate cancer	0.000189	0.0225	CbGeAlD
Sparfloxacin—TOP2A—Fulvestrant—Estradiol—prostate cancer	0.000181	0.0558	CbGdCrCtD
Sparfloxacin—TOP2A—Teniposide—Etoposide—prostate cancer	0.000159	0.0491	CbGdCrCtD
Sparfloxacin—TOP2A—Podofilox—Etoposide—prostate cancer	0.000159	0.0491	CbGdCrCtD
Sparfloxacin—TOP2A—Levorphanol—Estrone—prostate cancer	0.000158	0.0487	CbGdCrCtD
Sparfloxacin—ABCB1—bone marrow—prostate cancer	0.000146	0.0173	CbGeAlD
Sparfloxacin—Levofloxacin—CYP3A4—prostate cancer	0.000126	0.0436	CrCbGaD
Sparfloxacin—ABCB1—testis—prostate cancer	0.000125	0.0148	CbGeAlD
Sparfloxacin—Ciprofloxacin—CYP3A4—prostate cancer	0.000122	0.0421	CrCbGaD
Sparfloxacin—TOP2A—Levorphanol—Estradiol—prostate cancer	0.000119	0.0369	CbGdCrCtD
Sparfloxacin—TOP2A—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.000109	0.0337	CbGdCrCtD
Sparfloxacin—ABCB1—lymph node—prostate cancer	9.02e-05	0.0107	CbGeAlD
Sparfloxacin—TOP2A—Idarubicin—Epirubicin—prostate cancer	8.3e-05	0.0256	CbGdCrCtD
Sparfloxacin—TOP2A—Doxorubicin—Epirubicin—prostate cancer	8.3e-05	0.0256	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Epirubicin—prostate cancer	8.3e-05	0.0256	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Doxorubicin—prostate cancer	7.68e-05	0.0237	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Doxorubicin—prostate cancer	7.68e-05	0.0237	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Doxorubicin—prostate cancer	7.68e-05	0.0237	CbGdCrCtD
Sparfloxacin—TOP2A—Norethindrone—Ethinyl Estradiol—prostate cancer	7.11e-05	0.0219	CbGdCrCtD
Sparfloxacin—TOP2A—Levonorgestrel—Ethinyl Estradiol—prostate cancer	5.66e-05	0.0175	CbGdCrCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—SERPINE1—prostate cancer	4.03e-05	0.000963	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—AURKA—prostate cancer	3.95e-05	0.000943	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—prostate cancer	3.86e-05	0.000923	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	3.86e-05	0.000922	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—APEX1—prostate cancer	3.83e-05	0.000916	CbGpPWpGaD
Sparfloxacin—TOP2A—Methyltestosterone—Prednisone—prostate cancer	3.83e-05	0.0118	CbGdCrCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	3.8e-05	0.000908	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	3.79e-05	0.000906	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCG5—prostate cancer	3.79e-05	0.000905	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	3.75e-05	0.000895	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—PRKACB—prostate cancer	3.71e-05	0.000887	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—prostate cancer	3.7e-05	0.000884	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Mitoxantrone—prostate cancer	3.69e-05	0.000224	CcSEcCtD
Sparfloxacin—Dry mouth—Capecitabine—prostate cancer	3.68e-05	0.000223	CcSEcCtD
Sparfloxacin—Vomiting—Estradiol—prostate cancer	3.68e-05	0.000223	CcSEcCtD
Sparfloxacin—Agranulocytosis—Epirubicin—prostate cancer	3.68e-05	0.000223	CcSEcCtD
Sparfloxacin—Pneumonia—Doxorubicin—prostate cancer	3.67e-05	0.000223	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Etoposide—prostate cancer	3.67e-05	0.000223	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	3.66e-05	0.000876	CbGpPWpGaD
Sparfloxacin—Ill-defined disorder—Prednisone—prostate cancer	3.65e-05	0.000222	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Docetaxel—prostate cancer	3.65e-05	0.000222	CcSEcCtD
Sparfloxacin—Rash—Estradiol—prostate cancer	3.65e-05	0.000221	CcSEcCtD
Sparfloxacin—Dermatitis—Estradiol—prostate cancer	3.64e-05	0.000221	CcSEcCtD
Sparfloxacin—Confusional state—Capecitabine—prostate cancer	3.64e-05	0.000221	CcSEcCtD
Sparfloxacin—Tachycardia—Docetaxel—prostate cancer	3.64e-05	0.000221	CcSEcCtD
Sparfloxacin—Headache—Estradiol—prostate cancer	3.62e-05	0.00022	CcSEcCtD
Sparfloxacin—Agitation—Prednisone—prostate cancer	3.62e-05	0.00022	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	3.62e-05	0.00022	CcSEcCtD
Sparfloxacin—Angioedema—Prednisone—prostate cancer	3.6e-05	0.000218	CcSEcCtD
Sparfloxacin—Urticaria—Etoposide—prostate cancer	3.56e-05	0.000216	CcSEcCtD
Sparfloxacin—Haemoglobin—Epirubicin—prostate cancer	3.56e-05	0.000216	CcSEcCtD
Sparfloxacin—Jaundice—Doxorubicin—prostate cancer	3.55e-05	0.000216	CcSEcCtD
Sparfloxacin—Stomatitis—Doxorubicin—prostate cancer	3.55e-05	0.000216	CcSEcCtD
Sparfloxacin—Anorexia—Docetaxel—prostate cancer	3.55e-05	0.000216	CcSEcCtD
Sparfloxacin—Malaise—Prednisone—prostate cancer	3.55e-05	0.000216	CcSEcCtD
Sparfloxacin—Rhinitis—Epirubicin—prostate cancer	3.55e-05	0.000215	CcSEcCtD
Sparfloxacin—Abdominal pain—Etoposide—prostate cancer	3.54e-05	0.000215	CcSEcCtD
Sparfloxacin—Body temperature increased—Etoposide—prostate cancer	3.54e-05	0.000215	CcSEcCtD
Sparfloxacin—Urinary tract infection—Doxorubicin—prostate cancer	3.54e-05	0.000215	CcSEcCtD
Sparfloxacin—Conjunctivitis—Doxorubicin—prostate cancer	3.54e-05	0.000215	CcSEcCtD
Sparfloxacin—Vertigo—Prednisone—prostate cancer	3.54e-05	0.000215	CcSEcCtD
Sparfloxacin—Haemorrhage—Epirubicin—prostate cancer	3.54e-05	0.000215	CcSEcCtD
Sparfloxacin—Hepatitis—Epirubicin—prostate cancer	3.54e-05	0.000215	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Capecitabine—prostate cancer	3.53e-05	0.000214	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CHEK2—prostate cancer	3.53e-05	0.000844	CbGpPWpGaD
Sparfloxacin—Tachycardia—Capecitabine—prostate cancer	3.52e-05	0.000214	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Epirubicin—prostate cancer	3.52e-05	0.000214	CcSEcCtD
Sparfloxacin—Pharyngitis—Epirubicin—prostate cancer	3.51e-05	0.000213	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—prostate cancer	3.5e-05	0.000838	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.5e-05	0.000836	CbGpPWpGaD
Sparfloxacin—Sweating—Doxorubicin—prostate cancer	3.5e-05	0.000212	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Capecitabine—prostate cancer	3.49e-05	0.000212	CcSEcCtD
Sparfloxacin—Oedema peripheral—Epirubicin—prostate cancer	3.49e-05	0.000212	CcSEcCtD
Sparfloxacin—Haematuria—Doxorubicin—prostate cancer	3.48e-05	0.000211	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	3.47e-05	0.000829	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—prostate cancer	3.46e-05	0.000828	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—prostate cancer	3.45e-05	0.000824	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—prostate cancer	3.44e-05	0.000823	CbGpPWpGaD
Sparfloxacin—Epistaxis—Doxorubicin—prostate cancer	3.44e-05	0.000209	CcSEcCtD
Sparfloxacin—Anorexia—Capecitabine—prostate cancer	3.44e-05	0.000209	CcSEcCtD
Sparfloxacin—Nausea—Estradiol—prostate cancer	3.44e-05	0.000209	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—APEX1—prostate cancer	3.43e-05	0.000819	CbGpPWpGaD
Sparfloxacin—Vomiting—Mitoxantrone—prostate cancer	3.43e-05	0.000208	CcSEcCtD
Sparfloxacin—Sinusitis—Doxorubicin—prostate cancer	3.42e-05	0.000208	CcSEcCtD
Sparfloxacin—Convulsion—Prednisone—prostate cancer	3.41e-05	0.000207	CcSEcCtD
Sparfloxacin—Agranulocytosis—Doxorubicin—prostate cancer	3.4e-05	0.000207	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	3.4e-05	0.000813	CbGpPWpGaD
Sparfloxacin—Hypertension—Prednisone—prostate cancer	3.4e-05	0.000206	CcSEcCtD
Sparfloxacin—Rash—Mitoxantrone—prostate cancer	3.4e-05	0.000206	CcSEcCtD
Sparfloxacin—Dermatitis—Mitoxantrone—prostate cancer	3.4e-05	0.000206	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.39e-05	0.000206	CcSEcCtD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—prostate cancer	3.39e-05	0.000811	CbGpPWpGaD
Sparfloxacin—Headache—Mitoxantrone—prostate cancer	3.38e-05	0.000205	CcSEcCtD
Sparfloxacin—Insomnia—Docetaxel—prostate cancer	3.37e-05	0.000205	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—prostate cancer	3.36e-05	0.000803	CbGpPWpGaD
Sparfloxacin—Arthralgia—Prednisone—prostate cancer	3.35e-05	0.000204	CcSEcCtD
Sparfloxacin—Myalgia—Prednisone—prostate cancer	3.35e-05	0.000204	CcSEcCtD
Sparfloxacin—Paraesthesia—Docetaxel—prostate cancer	3.35e-05	0.000203	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	3.35e-05	0.0008	CbGpPWpGaD
Sparfloxacin—Erythema multiforme—Epirubicin—prostate cancer	3.34e-05	0.000203	CcSEcCtD
Sparfloxacin—Anxiety—Prednisone—prostate cancer	3.34e-05	0.000203	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.34e-05	0.000798	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Docetaxel—prostate cancer	3.32e-05	0.000202	CcSEcCtD
Sparfloxacin—Somnolence—Docetaxel—prostate cancer	3.31e-05	0.000201	CcSEcCtD
Sparfloxacin—Discomfort—Prednisone—prostate cancer	3.31e-05	0.000201	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	3.31e-05	0.000791	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND2—prostate cancer	3.31e-05	0.000791	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—BRCA1—prostate cancer	3.31e-05	0.000791	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Etoposide—prostate cancer	3.3e-05	0.000201	CcSEcCtD
Sparfloxacin—Tinnitus—Epirubicin—prostate cancer	3.3e-05	0.0002	CcSEcCtD
Sparfloxacin—Haemoglobin—Doxorubicin—prostate cancer	3.29e-05	0.0002	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.29e-05	0.0002	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—prostate cancer	3.28e-05	0.000785	CbGpPWpGaD
Sparfloxacin—Rhinitis—Doxorubicin—prostate cancer	3.28e-05	0.000199	CcSEcCtD
Sparfloxacin—Dyspepsia—Docetaxel—prostate cancer	3.28e-05	0.000199	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	3.28e-05	0.000783	CbGpPWpGaD
Sparfloxacin—Hepatitis—Doxorubicin—prostate cancer	3.27e-05	0.000199	CcSEcCtD
Sparfloxacin—Haemorrhage—Doxorubicin—prostate cancer	3.27e-05	0.000199	CcSEcCtD
Sparfloxacin—Insomnia—Capecitabine—prostate cancer	3.26e-05	0.000198	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Doxorubicin—prostate cancer	3.26e-05	0.000198	CcSEcCtD
Sparfloxacin—Pharyngitis—Doxorubicin—prostate cancer	3.25e-05	0.000197	CcSEcCtD
Sparfloxacin—Paraesthesia—Capecitabine—prostate cancer	3.24e-05	0.000197	CcSEcCtD
Sparfloxacin—Decreased appetite—Docetaxel—prostate cancer	3.24e-05	0.000197	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—prostate cancer	3.23e-05	0.000773	CbGpPWpGaD
Sparfloxacin—Oedema peripheral—Doxorubicin—prostate cancer	3.22e-05	0.000196	CcSEcCtD
Sparfloxacin—Asthenia—Etoposide—prostate cancer	3.22e-05	0.000195	CcSEcCtD
Sparfloxacin—Dyspnoea—Capecitabine—prostate cancer	3.22e-05	0.000195	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Prednisone—prostate cancer	3.21e-05	0.000195	CcSEcCtD
Sparfloxacin—Nausea—Mitoxantrone—prostate cancer	3.2e-05	0.000194	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	3.2e-05	0.000765	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	3.19e-05	0.000764	CbGpPWpGaD
Sparfloxacin—Pain—Docetaxel—prostate cancer	3.19e-05	0.000193	CcSEcCtD
Sparfloxacin—Constipation—Docetaxel—prostate cancer	3.19e-05	0.000193	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—GNG5—prostate cancer	3.18e-05	0.000761	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—prostate cancer	3.18e-05	0.000761	CbGpPWpGaD
Sparfloxacin—Dyspepsia—Capecitabine—prostate cancer	3.18e-05	0.000193	CcSEcCtD
Sparfloxacin—Chills—Epirubicin—prostate cancer	3.17e-05	0.000193	CcSEcCtD
Sparfloxacin—Pruritus—Etoposide—prostate cancer	3.17e-05	0.000193	CcSEcCtD
Sparfloxacin—Arrhythmia—Epirubicin—prostate cancer	3.16e-05	0.000192	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—prostate cancer	3.15e-05	0.000752	CbGpPWpGaD
Sparfloxacin—Tachycardia—Prednisone—prostate cancer	3.14e-05	0.00019	CcSEcCtD
Sparfloxacin—Decreased appetite—Capecitabine—prostate cancer	3.14e-05	0.00019	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—prostate cancer	3.13e-05	0.000749	CbGpPWpGaD
Sparfloxacin—Alopecia—Epirubicin—prostate cancer	3.13e-05	0.00019	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Prednisone—prostate cancer	3.11e-05	0.000189	CcSEcCtD
Sparfloxacin—Erythema multiforme—Doxorubicin—prostate cancer	3.1e-05	0.000188	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—prostate cancer	3.09e-05	0.000738	CbGpPWpGaD
Sparfloxacin—Pain—Capecitabine—prostate cancer	3.09e-05	0.000187	CcSEcCtD
Sparfloxacin—Constipation—Capecitabine—prostate cancer	3.09e-05	0.000187	CcSEcCtD
Sparfloxacin—Feeling abnormal—Docetaxel—prostate cancer	3.07e-05	0.000186	CcSEcCtD
Sparfloxacin—Diarrhoea—Etoposide—prostate cancer	3.07e-05	0.000186	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—PTEN—prostate cancer	3.07e-05	0.000733	CbGpPWpGaD
Sparfloxacin—Anorexia—Prednisone—prostate cancer	3.06e-05	0.000186	CcSEcCtD
Sparfloxacin—Tinnitus—Doxorubicin—prostate cancer	3.05e-05	0.000185	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Docetaxel—prostate cancer	3.05e-05	0.000185	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	3.05e-05	0.000728	CbGpPWpGaD
Sparfloxacin—Flatulence—Epirubicin—prostate cancer	3.03e-05	0.000184	CcSEcCtD
Sparfloxacin—Tension—Epirubicin—prostate cancer	3.02e-05	0.000183	CcSEcCtD
Sparfloxacin—Dysgeusia—Epirubicin—prostate cancer	3.02e-05	0.000183	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	2.99e-05	0.000716	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—BRCA2—prostate cancer	2.99e-05	0.000715	CbGpPWpGaD
Sparfloxacin—Nervousness—Epirubicin—prostate cancer	2.99e-05	0.000182	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—prostate cancer	2.99e-05	0.000715	CbGpPWpGaD
Sparfloxacin—Back pain—Epirubicin—prostate cancer	2.98e-05	0.000181	CcSEcCtD
Sparfloxacin—Feeling abnormal—Capecitabine—prostate cancer	2.97e-05	0.000181	CcSEcCtD
Sparfloxacin—Dizziness—Etoposide—prostate cancer	2.97e-05	0.00018	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	2.96e-05	0.000708	CbGpPWpGaD
Sparfloxacin—Gastrointestinal pain—Capecitabine—prostate cancer	2.95e-05	0.000179	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.95e-05	0.000705	CbGpPWpGaD
Sparfloxacin—Body temperature increased—Docetaxel—prostate cancer	2.95e-05	0.000179	CcSEcCtD
Sparfloxacin—Abdominal pain—Docetaxel—prostate cancer	2.95e-05	0.000179	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—prostate cancer	2.94e-05	0.000702	CbGpPWpGaD
Sparfloxacin—Chills—Doxorubicin—prostate cancer	2.94e-05	0.000178	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Prednisone—prostate cancer	2.93e-05	0.000178	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—EP300—prostate cancer	2.92e-05	0.000699	CbGpPWpGaD
Sparfloxacin—Arrhythmia—Doxorubicin—prostate cancer	2.92e-05	0.000178	CcSEcCtD
Sparfloxacin—Insomnia—Prednisone—prostate cancer	2.91e-05	0.000176	CcSEcCtD
Sparfloxacin—Alopecia—Doxorubicin—prostate cancer	2.89e-05	0.000176	CcSEcCtD
Sparfloxacin—Paraesthesia—Prednisone—prostate cancer	2.89e-05	0.000175	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	2.89e-05	0.00069	CbGpPWpGaD
Sparfloxacin—Urticaria—Capecitabine—prostate cancer	2.87e-05	0.000174	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Epirubicin—prostate cancer	2.86e-05	0.000173	CcSEcCtD
Sparfloxacin—Body temperature increased—Capecitabine—prostate cancer	2.85e-05	0.000173	CcSEcCtD
Sparfloxacin—Abdominal pain—Capecitabine—prostate cancer	2.85e-05	0.000173	CcSEcCtD
Sparfloxacin—Vomiting—Etoposide—prostate cancer	2.85e-05	0.000173	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—TYMS—prostate cancer	2.85e-05	0.00068	CbGpPWpGaD
Sparfloxacin—Agitation—Epirubicin—prostate cancer	2.83e-05	0.000172	CcSEcCtD
Sparfloxacin—Dyspepsia—Prednisone—prostate cancer	2.83e-05	0.000172	CcSEcCtD
Sparfloxacin—Rash—Etoposide—prostate cancer	2.83e-05	0.000172	CcSEcCtD
Sparfloxacin—Dermatitis—Etoposide—prostate cancer	2.82e-05	0.000172	CcSEcCtD
Sparfloxacin—Headache—Etoposide—prostate cancer	2.81e-05	0.000171	CcSEcCtD
Sparfloxacin—Flatulence—Doxorubicin—prostate cancer	2.81e-05	0.00017	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—RXRA—prostate cancer	2.8e-05	0.00067	CbGpPWpGaD
Sparfloxacin—Tension—Doxorubicin—prostate cancer	2.8e-05	0.00017	CcSEcCtD
Sparfloxacin—Decreased appetite—Prednisone—prostate cancer	2.79e-05	0.00017	CcSEcCtD
Sparfloxacin—Dysgeusia—Doxorubicin—prostate cancer	2.79e-05	0.000169	CcSEcCtD
Sparfloxacin—Malaise—Epirubicin—prostate cancer	2.78e-05	0.000169	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—prostate cancer	2.77e-05	0.000662	CbGpPWpGaD
Sparfloxacin—Nervousness—Doxorubicin—prostate cancer	2.77e-05	0.000168	CcSEcCtD
Sparfloxacin—Vertigo—Epirubicin—prostate cancer	2.77e-05	0.000168	CcSEcCtD
Sparfloxacin—Back pain—Doxorubicin—prostate cancer	2.76e-05	0.000167	CcSEcCtD
Sparfloxacin—Constipation—Prednisone—prostate cancer	2.75e-05	0.000167	CcSEcCtD
Sparfloxacin—Hypersensitivity—Docetaxel—prostate cancer	2.75e-05	0.000167	CcSEcCtD
Sparfloxacin—Palpitations—Epirubicin—prostate cancer	2.72e-05	0.000165	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PRKACB—prostate cancer	2.71e-05	0.000648	CbGpPWpGaD
Sparfloxacin—Cough—Epirubicin—prostate cancer	2.69e-05	0.000163	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—prostate cancer	2.69e-05	0.000642	CbGpPWpGaD
Sparfloxacin—Asthenia—Docetaxel—prostate cancer	2.67e-05	0.000162	CcSEcCtD
Sparfloxacin—Convulsion—Epirubicin—prostate cancer	2.67e-05	0.000162	CcSEcCtD
Sparfloxacin—Nausea—Etoposide—prostate cancer	2.66e-05	0.000162	CcSEcCtD
Sparfloxacin—Hypertension—Epirubicin—prostate cancer	2.66e-05	0.000161	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—prostate cancer	2.66e-05	0.000635	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Capecitabine—prostate cancer	2.66e-05	0.000161	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	2.65e-05	0.000635	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	2.65e-05	0.000633	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Prednisone—prostate cancer	2.65e-05	0.000161	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Doxorubicin—prostate cancer	2.64e-05	0.000161	CcSEcCtD
Sparfloxacin—Pruritus—Docetaxel—prostate cancer	2.64e-05	0.00016	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Prednisone—prostate cancer	2.63e-05	0.00016	CcSEcCtD
Sparfloxacin—Arthralgia—Epirubicin—prostate cancer	2.62e-05	0.000159	CcSEcCtD
Sparfloxacin—Myalgia—Epirubicin—prostate cancer	2.62e-05	0.000159	CcSEcCtD
Sparfloxacin—Chest pain—Epirubicin—prostate cancer	2.62e-05	0.000159	CcSEcCtD
Sparfloxacin—Agitation—Doxorubicin—prostate cancer	2.62e-05	0.000159	CcSEcCtD
Sparfloxacin—Anxiety—Epirubicin—prostate cancer	2.61e-05	0.000159	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	2.6e-05	0.000621	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—prostate cancer	2.6e-05	0.00062	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—prostate cancer	2.59e-05	0.00062	CbGpPWpGaD
Sparfloxacin—Discomfort—Epirubicin—prostate cancer	2.59e-05	0.000157	CcSEcCtD
Sparfloxacin—Asthenia—Capecitabine—prostate cancer	2.59e-05	0.000157	CcSEcCtD
Sparfloxacin—Malaise—Doxorubicin—prostate cancer	2.57e-05	0.000156	CcSEcCtD
Sparfloxacin—Dry mouth—Epirubicin—prostate cancer	2.56e-05	0.000156	CcSEcCtD
Sparfloxacin—Vertigo—Doxorubicin—prostate cancer	2.56e-05	0.000155	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.56e-05	0.000612	CbGpPWpGaD
Sparfloxacin—Urticaria—Prednisone—prostate cancer	2.55e-05	0.000155	CcSEcCtD
Sparfloxacin—Pruritus—Capecitabine—prostate cancer	2.55e-05	0.000155	CcSEcCtD
Sparfloxacin—Diarrhoea—Docetaxel—prostate cancer	2.55e-05	0.000155	CcSEcCtD
Sparfloxacin—Body temperature increased—Prednisone—prostate cancer	2.54e-05	0.000154	CcSEcCtD
Sparfloxacin—Abdominal pain—Prednisone—prostate cancer	2.54e-05	0.000154	CcSEcCtD
Sparfloxacin—Confusional state—Epirubicin—prostate cancer	2.53e-05	0.000154	CcSEcCtD
Sparfloxacin—Palpitations—Doxorubicin—prostate cancer	2.52e-05	0.000153	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—prostate cancer	2.52e-05	0.000601	CbGpPWpGaD
Sparfloxacin—Anaphylactic shock—Epirubicin—prostate cancer	2.51e-05	0.000153	CcSEcCtD
Sparfloxacin—Cough—Doxorubicin—prostate cancer	2.49e-05	0.000151	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—TERT—prostate cancer	2.48e-05	0.000592	CbGpPWpGaD
Sparfloxacin—Convulsion—Doxorubicin—prostate cancer	2.47e-05	0.00015	CcSEcCtD
Sparfloxacin—Diarrhoea—Capecitabine—prostate cancer	2.47e-05	0.00015	CcSEcCtD
Sparfloxacin—Dizziness—Docetaxel—prostate cancer	2.46e-05	0.00015	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Epirubicin—prostate cancer	2.46e-05	0.000149	CcSEcCtD
Sparfloxacin—Hypertension—Doxorubicin—prostate cancer	2.46e-05	0.000149	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	2.45e-05	0.000586	CbGpPWpGaD
Sparfloxacin—Tachycardia—Epirubicin—prostate cancer	2.45e-05	0.000149	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—prostate cancer	2.45e-05	0.000585	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	2.44e-05	0.000584	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.44e-05	0.000583	CbGpPWpGaD
Sparfloxacin—Hyperhidrosis—Epirubicin—prostate cancer	2.43e-05	0.000148	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—prostate cancer	2.43e-05	0.00058	CbGpPWpGaD
Sparfloxacin—Myalgia—Doxorubicin—prostate cancer	2.43e-05	0.000147	CcSEcCtD
Sparfloxacin—Chest pain—Doxorubicin—prostate cancer	2.43e-05	0.000147	CcSEcCtD
Sparfloxacin—Arthralgia—Doxorubicin—prostate cancer	2.43e-05	0.000147	CcSEcCtD
Sparfloxacin—Anxiety—Doxorubicin—prostate cancer	2.42e-05	0.000147	CcSEcCtD
Sparfloxacin—Discomfort—Doxorubicin—prostate cancer	2.4e-05	0.000146	CcSEcCtD
Sparfloxacin—Anorexia—Epirubicin—prostate cancer	2.4e-05	0.000145	CcSEcCtD
Sparfloxacin—Dizziness—Capecitabine—prostate cancer	2.39e-05	0.000145	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	2.38e-05	0.000569	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	2.38e-05	0.000569	CbGpPWpGaD
Sparfloxacin—Dry mouth—Doxorubicin—prostate cancer	2.37e-05	0.000144	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—CXCL8—prostate cancer	2.37e-05	0.000567	CbGpPWpGaD
Sparfloxacin—Vomiting—Docetaxel—prostate cancer	2.37e-05	0.000144	CcSEcCtD
Sparfloxacin—Hypersensitivity—Prednisone—prostate cancer	2.37e-05	0.000144	CcSEcCtD
Sparfloxacin—Rash—Docetaxel—prostate cancer	2.35e-05	0.000143	CcSEcCtD
Sparfloxacin—Dermatitis—Docetaxel—prostate cancer	2.35e-05	0.000143	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—EP300—prostate cancer	2.35e-05	0.000561	CbGpPWpGaD
Sparfloxacin—Confusional state—Doxorubicin—prostate cancer	2.34e-05	0.000142	CcSEcCtD
Sparfloxacin—Headache—Docetaxel—prostate cancer	2.33e-05	0.000142	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Doxorubicin—prostate cancer	2.33e-05	0.000141	CcSEcCtD
Sparfloxacin—Asthenia—Prednisone—prostate cancer	2.31e-05	0.00014	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—TGFB1—prostate cancer	2.3e-05	0.00055	CbGpPWpGaD
Sparfloxacin—Vomiting—Capecitabine—prostate cancer	2.29e-05	0.000139	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.29e-05	0.000139	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Doxorubicin—prostate cancer	2.28e-05	0.000138	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	2.28e-05	0.000544	CbGpPWpGaD
Sparfloxacin—Rash—Capecitabine—prostate cancer	2.27e-05	0.000138	CcSEcCtD
Sparfloxacin—Pruritus—Prednisone—prostate cancer	2.27e-05	0.000138	CcSEcCtD
Sparfloxacin—Insomnia—Epirubicin—prostate cancer	2.27e-05	0.000138	CcSEcCtD
Sparfloxacin—Dermatitis—Capecitabine—prostate cancer	2.27e-05	0.000138	CcSEcCtD
Sparfloxacin—Tachycardia—Doxorubicin—prostate cancer	2.27e-05	0.000138	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—CASP3—prostate cancer	2.27e-05	0.000542	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL2—prostate cancer	2.27e-05	0.000541	CbGpPWpGaD
Sparfloxacin—Headache—Capecitabine—prostate cancer	2.26e-05	0.000137	CcSEcCtD
Sparfloxacin—Paraesthesia—Epirubicin—prostate cancer	2.26e-05	0.000137	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	2.25e-05	0.000539	CbGpPWpGaD
Sparfloxacin—Hyperhidrosis—Doxorubicin—prostate cancer	2.25e-05	0.000137	CcSEcCtD
Sparfloxacin—Dyspnoea—Epirubicin—prostate cancer	2.24e-05	0.000136	CcSEcCtD
Sparfloxacin—Somnolence—Epirubicin—prostate cancer	2.23e-05	0.000136	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	2.23e-05	0.000533	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—ATM—prostate cancer	2.23e-05	0.000533	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—prostate cancer	2.22e-05	0.000531	CbGpPWpGaD
Sparfloxacin—Anorexia—Doxorubicin—prostate cancer	2.22e-05	0.000135	CcSEcCtD
Sparfloxacin—Nausea—Docetaxel—prostate cancer	2.21e-05	0.000134	CcSEcCtD
Sparfloxacin—Dyspepsia—Epirubicin—prostate cancer	2.21e-05	0.000134	CcSEcCtD
Sparfloxacin—Diarrhoea—Prednisone—prostate cancer	2.2e-05	0.000134	CcSEcCtD
Sparfloxacin—Decreased appetite—Epirubicin—prostate cancer	2.18e-05	0.000133	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.18e-05	0.000521	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HAO1—prostate cancer	2.18e-05	0.00052	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	2.16e-05	0.000517	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.16e-05	0.000515	CbGpPWpGaD
Sparfloxacin—Pain—Epirubicin—prostate cancer	2.15e-05	0.000131	CcSEcCtD
Sparfloxacin—Constipation—Epirubicin—prostate cancer	2.15e-05	0.000131	CcSEcCtD
Sparfloxacin—Nausea—Capecitabine—prostate cancer	2.14e-05	0.00013	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—PPARA—prostate cancer	2.14e-05	0.000512	CbGpPWpGaD
Sparfloxacin—Dizziness—Prednisone—prostate cancer	2.13e-05	0.000129	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.12e-05	0.000129	CcSEcCtD
Sparfloxacin—Insomnia—Doxorubicin—prostate cancer	2.1e-05	0.000128	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—TP53—prostate cancer	2.09e-05	0.0005	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Doxorubicin—prostate cancer	2.09e-05	0.000127	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	2.09e-05	0.000498	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Doxorubicin—prostate cancer	2.07e-05	0.000126	CcSEcCtD
Sparfloxacin—Feeling abnormal—Epirubicin—prostate cancer	2.07e-05	0.000126	CcSEcCtD
Sparfloxacin—Somnolence—Doxorubicin—prostate cancer	2.07e-05	0.000126	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Epirubicin—prostate cancer	2.06e-05	0.000125	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—RXRA—prostate cancer	2.05e-05	0.00049	CbGpPWpGaD
Sparfloxacin—Dyspepsia—Doxorubicin—prostate cancer	2.05e-05	0.000124	CcSEcCtD
Sparfloxacin—Vomiting—Prednisone—prostate cancer	2.04e-05	0.000124	CcSEcCtD
Sparfloxacin—Rash—Prednisone—prostate cancer	2.03e-05	0.000123	CcSEcCtD
Sparfloxacin—Dermatitis—Prednisone—prostate cancer	2.02e-05	0.000123	CcSEcCtD
Sparfloxacin—Decreased appetite—Doxorubicin—prostate cancer	2.02e-05	0.000123	CcSEcCtD
Sparfloxacin—Headache—Prednisone—prostate cancer	2.01e-05	0.000122	CcSEcCtD
Sparfloxacin—Urticaria—Epirubicin—prostate cancer	2e-05	0.000121	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	1.99e-05	0.000475	CbGpPWpGaD
Sparfloxacin—Constipation—Doxorubicin—prostate cancer	1.99e-05	0.000121	CcSEcCtD
Sparfloxacin—Pain—Doxorubicin—prostate cancer	1.99e-05	0.000121	CcSEcCtD
Sparfloxacin—Body temperature increased—Epirubicin—prostate cancer	1.99e-05	0.000121	CcSEcCtD
Sparfloxacin—Abdominal pain—Epirubicin—prostate cancer	1.99e-05	0.000121	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	1.93e-05	0.000461	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—VEGFA—prostate cancer	1.93e-05	0.00046	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Doxorubicin—prostate cancer	1.92e-05	0.000116	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—IL6—prostate cancer	1.92e-05	0.000458	CbGpPWpGaD
Sparfloxacin—Nausea—Prednisone—prostate cancer	1.91e-05	0.000116	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Doxorubicin—prostate cancer	1.9e-05	0.000115	CcSEcCtD
Sparfloxacin—Hypersensitivity—Epirubicin—prostate cancer	1.85e-05	0.000112	CcSEcCtD
Sparfloxacin—Urticaria—Doxorubicin—prostate cancer	1.85e-05	0.000112	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.84e-05	0.00044	CbGpPWpGaD
Sparfloxacin—Abdominal pain—Doxorubicin—prostate cancer	1.84e-05	0.000112	CcSEcCtD
Sparfloxacin—Body temperature increased—Doxorubicin—prostate cancer	1.84e-05	0.000112	CcSEcCtD
Sparfloxacin—Asthenia—Epirubicin—prostate cancer	1.8e-05	0.000109	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCG5—prostate cancer	1.78e-05	0.000426	CbGpPWpGaD
Sparfloxacin—Pruritus—Epirubicin—prostate cancer	1.78e-05	0.000108	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—CSAD—prostate cancer	1.77e-05	0.000424	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CBR1—prostate cancer	1.77e-05	0.000424	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TST—prostate cancer	1.77e-05	0.000424	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ADI1—prostate cancer	1.77e-05	0.000424	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GRHL1—prostate cancer	1.77e-05	0.000424	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PSAT1—prostate cancer	1.77e-05	0.000424	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—TGFB1—prostate cancer	1.77e-05	0.000422	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Epirubicin—prostate cancer	1.72e-05	0.000104	CcSEcCtD
Sparfloxacin—Hypersensitivity—Doxorubicin—prostate cancer	1.71e-05	0.000104	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.7e-05	0.000407	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	1.69e-05	0.000405	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	1.68e-05	0.000402	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—prostate cancer	1.68e-05	0.000401	CbGpPWpGaD
Sparfloxacin—Asthenia—Doxorubicin—prostate cancer	1.67e-05	0.000101	CcSEcCtD
Sparfloxacin—Dizziness—Epirubicin—prostate cancer	1.66e-05	0.000101	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—GRHPR—prostate cancer	1.65e-05	0.000394	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UGT2B17—prostate cancer	1.65e-05	0.000394	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UGT2B15—prostate cancer	1.65e-05	0.000394	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CKMT2—prostate cancer	1.65e-05	0.000394	CbGpPWpGaD
Sparfloxacin—Pruritus—Doxorubicin—prostate cancer	1.65e-05	9.99e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—MDM2—prostate cancer	1.64e-05	0.000393	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	1.64e-05	0.000392	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—prostate cancer	1.6e-05	0.000383	CbGpPWpGaD
Sparfloxacin—Vomiting—Epirubicin—prostate cancer	1.6e-05	9.7e-05	CcSEcCtD
Sparfloxacin—Diarrhoea—Doxorubicin—prostate cancer	1.59e-05	9.66e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	1.59e-05	0.00038	CbGpPWpGaD
Sparfloxacin—Rash—Epirubicin—prostate cancer	1.58e-05	9.62e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Epirubicin—prostate cancer	1.58e-05	9.61e-05	CcSEcCtD
Sparfloxacin—Headache—Epirubicin—prostate cancer	1.57e-05	9.56e-05	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.57e-05	0.000376	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	1.57e-05	0.000375	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—PPARA—prostate cancer	1.57e-05	0.000374	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM3—prostate cancer	1.55e-05	0.000371	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PGAM2—prostate cancer	1.55e-05	0.000371	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MBTPS1—prostate cancer	1.55e-05	0.000371	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NAGLU—prostate cancer	1.55e-05	0.000371	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SULT2B1—prostate cancer	1.55e-05	0.000371	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—RFK—prostate cancer	1.55e-05	0.000371	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AOX1—prostate cancer	1.55e-05	0.000371	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—prostate cancer	1.55e-05	0.00037	CbGpPWpGaD
Sparfloxacin—Dizziness—Doxorubicin—prostate cancer	1.54e-05	9.34e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1B—prostate cancer	1.5e-05	0.000359	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	1.5e-05	0.000358	CbGpPWpGaD
Sparfloxacin—Nausea—Epirubicin—prostate cancer	1.49e-05	9.06e-05	CcSEcCtD
Sparfloxacin—Vomiting—Doxorubicin—prostate cancer	1.48e-05	8.98e-05	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—EP300—prostate cancer	1.47e-05	0.000353	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	1.47e-05	0.000352	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AMACR—prostate cancer	1.47e-05	0.000351	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP3A43—prostate cancer	1.47e-05	0.000351	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—DEGS1—prostate cancer	1.47e-05	0.000351	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SRD5A2—prostate cancer	1.47e-05	0.000351	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NAT1—prostate cancer	1.47e-05	0.000351	CbGpPWpGaD
Sparfloxacin—Rash—Doxorubicin—prostate cancer	1.47e-05	8.9e-05	CcSEcCtD
Sparfloxacin—Dermatitis—Doxorubicin—prostate cancer	1.46e-05	8.9e-05	CcSEcCtD
Sparfloxacin—Headache—Doxorubicin—prostate cancer	1.46e-05	8.85e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	1.45e-05	0.000348	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND1—prostate cancer	1.43e-05	0.000342	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	1.42e-05	0.000339	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	1.41e-05	0.000336	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HSD17B1—prostate cancer	1.4e-05	0.000335	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1A—prostate cancer	1.39e-05	0.000331	CbGpPWpGaD
Sparfloxacin—Nausea—Doxorubicin—prostate cancer	1.38e-05	8.39e-05	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	1.34e-05	0.00032	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—EP300—prostate cancer	1.32e-05	0.000315	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—prostate cancer	1.29e-05	0.000307	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.28e-05	0.000305	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	1.27e-05	0.000303	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	1.25e-05	0.000299	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HPGD—prostate cancer	1.25e-05	0.000299	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—B4GALT4—prostate cancer	1.25e-05	0.000299	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.24e-05	0.000297	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	1.23e-05	0.000295	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.21e-05	0.000288	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.2e-05	0.000288	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TNFRSF21—prostate cancer	1.18e-05	0.000281	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MYC—prostate cancer	1.15e-05	0.000275	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.15e-05	0.000274	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP7B1—prostate cancer	1.14e-05	0.000273	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTAP—prostate cancer	1.14e-05	0.000273	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.14e-05	0.000273	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.12e-05	0.000268	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SULT1E1—prostate cancer	1.11e-05	0.000266	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SRD5A1—prostate cancer	1.11e-05	0.000266	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.09e-05	0.00026	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.08e-05	0.000258	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ACSL4—prostate cancer	1.06e-05	0.000254	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HSD17B3—prostate cancer	1.06e-05	0.000254	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.05e-05	0.000252	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.05e-05	0.000251	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ARG2—prostate cancer	1.02e-05	0.000244	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UMPS—prostate cancer	1.02e-05	0.000244	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PHGDH—prostate cancer	1.02e-05	0.000244	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.01e-05	0.000242	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1e-05	0.00024	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LDHB—prostate cancer	9.99e-06	0.000239	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP3A5—prostate cancer	9.81e-06	0.000234	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	9.76e-06	0.000233	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	9.64e-06	0.00023	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	9.5e-06	0.000227	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PDHA1—prostate cancer	9.47e-06	0.000226	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TCN2—prostate cancer	9.47e-06	0.000226	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UCP3—prostate cancer	9.47e-06	0.000226	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA3—prostate cancer	9.47e-06	0.000226	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TP53—prostate cancer	9.44e-06	0.000226	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC22A3—prostate cancer	9.04e-06	0.000216	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HSD3B1—prostate cancer	9.04e-06	0.000216	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	8.74e-06	0.000209	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	8.72e-06	0.000208	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TBXAS1—prostate cancer	8.67e-06	0.000207	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA4—prostate cancer	8.67e-06	0.000207	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	8.55e-06	0.000204	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA2—prostate cancer	8.44e-06	0.000202	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCG5—prostate cancer	8.34e-06	0.000199	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SULT1A1—prostate cancer	8.34e-06	0.000199	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA1—prostate cancer	8.15e-06	0.000195	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	8.08e-06	0.000193	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTO1—prostate cancer	8.06e-06	0.000193	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HSD3B2—prostate cancer	8.06e-06	0.000193	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NAT2—prostate cancer	8.06e-06	0.000193	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLCB2—prostate cancer	7.72e-06	0.000185	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LRP2—prostate cancer	7.72e-06	0.000185	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP2C18—prostate cancer	7.72e-06	0.000185	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—P4HB—prostate cancer	7.57e-06	0.000181	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	7.42e-06	0.000177	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC22A1—prostate cancer	7.37e-06	0.000176	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	7.37e-06	0.000176	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SULT2A1—prostate cancer	7.18e-06	0.000172	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	7.18e-06	0.000172	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MED12—prostate cancer	7.06e-06	0.000169	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GNG5—prostate cancer	7.01e-06	0.000168	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOA3—prostate cancer	6.75e-06	0.000161	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HPGDS—prostate cancer	6.44e-06	0.000154	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP2C19—prostate cancer	6.4e-06	0.000153	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTT1—prostate cancer	6.25e-06	0.000149	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ACHE—prostate cancer	6.25e-06	0.000149	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP2A6—prostate cancer	6.17e-06	0.000148	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	6.06e-06	0.000145	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKR1C3—prostate cancer	6.01e-06	0.000144	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PRKACB—prostate cancer	5.97e-06	0.000143	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP17A1—prostate cancer	5.91e-06	0.000141	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.85e-06	0.00014	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOA2—prostate cancer	5.63e-06	0.000135	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SLC5A5—prostate cancer	5.38e-06	0.000128	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP2E1—prostate cancer	5.25e-06	0.000125	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NQO1—prostate cancer	5.19e-06	0.000124	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TH—prostate cancer	5.12e-06	0.000122	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP3A4—prostate cancer	5.06e-06	0.000121	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP1B1—prostate cancer	4.98e-06	0.000119	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GGT1—prostate cancer	4.82e-06	0.000115	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOA1—prostate cancer	4.75e-06	0.000113	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP19A1—prostate cancer	4.68e-06	0.000112	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—RXRA—prostate cancer	4.52e-06	0.000108	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—COMT—prostate cancer	4.35e-06	0.000104	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTP1—prostate cancer	4.33e-06	0.000103	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ITPR1—prostate cancer	4.26e-06	0.000102	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TYMS—prostate cancer	4.03e-06	9.62e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM1—prostate cancer	3.98e-06	9.51e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—LPL—prostate cancer	3.91e-06	9.33e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP1A1—prostate cancer	3.77e-06	9.02e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ERCC2—prostate cancer	3.74e-06	8.94e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTHFR—prostate cancer	3.52e-06	8.4e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPARA—prostate cancer	3.45e-06	8.25e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CAV1—prostate cancer	3.24e-06	7.75e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CG—prostate cancer	2.95e-06	7.06e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—INS—prostate cancer	2.8e-06	6.68e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CREBBP—prostate cancer	2.74e-06	6.55e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CD—prostate cancer	2.6e-06	6.21e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NOS3—prostate cancer	2.45e-06	5.86e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CB—prostate cancer	2.26e-06	5.41e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS2—prostate cancer	2.24e-06	5.36e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTEN—prostate cancer	1.96e-06	4.68e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—EP300—prostate cancer	1.87e-06	4.46e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CA—prostate cancer	1.38e-06	3.3e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKT1—prostate cancer	1.13e-06	2.69e-05	CbGpPWpGaD
